Rituximab in multiple sclerosis at general hospital level-Reference-Cited by-同舟云学术

Rituximab in multiple sclerosis at general hospital level

Published:2020-02-06 Issue:6 Volume:141 Page:491-499
ISSN:0001-6314
Container-title:Acta Neurologica Scandinavica
language:en
Short-container-title:Acta Neurol Scand

Author:

Hellgren Johan¹,Risedal Anette¹²,Källén Kristina¹²^ORCID

Affiliation:

1. Medical Faculty Department of Clinical Sciences Lund Lund University Lund Sweden

2. Department of Specialized Medicine Helsingborg General Hospital Helsingborg Sweden

Publisher

Wiley

Subject

Neurology (clinical),Neurology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ane.13225

Reference25 articles.

1. Läkemedelsverket.Läkemedelsbehandling vid multipel skleros (MS) ‐ behandlingsrekommendation: Information från Läkemedelsverket.2015.https://lakemedelsverket.se/upload/halso-och-sjukvard/behandlingsrekommendationer/Lakemedelsbehandling_av_multipel_skleros_MS_behandlingsrekommendation_webb.pdf. Accessed December 21 2015.

2. Rituximab is an acceptable alternative to ocrelizumab for treating multiple sclerosis – Yes

3. Rapidly increasing off-label use of rituximab in multiple sclerosis in Sweden - Outlier or predecessor?

4. Rituximab for rheumatoid arthritis;Lopez‐Olivo MA;Cochrane Database Syst Rev,2015

5. Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Urinary tract microbiota in patients with multiple sclerosis and neurogenic pelvic dysfunction;Bulletin of Siberian Medicine;2024-07-11

2. The landscape of real-world evidence of rituximab utilization and clinical outcomes in patients with cancer, rheumatoid arthritis, and multiple sclerosis: A scoping review;Journal of Managed Care & Specialty Pharmacy;2024-05

3. Systematic Literature Review on the Incidence of Herpes Zoster in Populations at Increased Risk of Disease in the EU/EEA, Switzerland, and the UK;Infectious Diseases and Therapy;2024-04-24

4. A comparative study of fatigue and processing speed in patients with multiple sclerosis treated with natalizumab or rituximab;Multiple Sclerosis Journal - Experimental, Translational and Clinical;2024-04

5. Efficacy and safety of rituximab in multiple sclerosis: a systematic review and meta-analysis;Acta Neurologica Belgica;2023-07-10